Pharmacological fibrinolysis.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use; D008691:Methadone / Q000627:therapeutic use; D009277:Nandrolone / Q000627:therapeutic use; D010629:Phenformin / Q000008:administration & dosage / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D003692:Delayed-Action Preparations; D013453:Sulfonylurea Compounds; D013739:Testosterone; D009277:Nandrolone; D005337:Fibrin; D000324:Adrenocorticotropic Hormone; D008687:Metformin; D005032:Ethylestrenol; D010629:Phenformin; D002994:Clofibrate; D008691:Methadone